PARP inhibitors can be effective in broader group of patients

A pioneering class of drugs that target cancers with mutations in the BRCA breast cancer genes could also work against tumours with another type of genetic fault, a new study suggests.



from The Medical News http://ift.tt/1C3Djiq

No comments:

Post a Comment